These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 20021835)
1. [Comparison of response evaluation methods of neoadjuvant chemotherapy in breast cancer patients]. Sun B; Song ST; Wu SK; Jiang ZF; Wang T; Zhang SH; Zhao YB; Yu CZ; Li XB; Yang T; Li GJ Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):783-5. PubMed ID: 20021835 [TBL] [Abstract][Full Text] [Related]
2. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy. Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493 [TBL] [Abstract][Full Text] [Related]
3. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Herrada J; Iyer RB; Atkinson EN; Sneige N; Buzdar AU; Hortobagyi GN Clin Cancer Res; 1997 Sep; 3(9):1565-9. PubMed ID: 9815844 [TBL] [Abstract][Full Text] [Related]
4. [The feasibility and the role of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer]. Péley G; Török K; Farkas E; Mátrai Z; Horváth Z; Sinkovics I; Hitre E; Rényi-Vámos F; Orosz Z; Köves I Magy Onkol; 2006; 50(1):19-23. PubMed ID: 16617379 [TBL] [Abstract][Full Text] [Related]
5. Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study. Morency D; Dumitra S; Parvez E; Martel K; Basik M; Robidoux A; Poirier B; Holloway CMB; Gaboury L; Sideris L; Meterissian S; Boileau JF Ann Surg Oncol; 2019 Dec; 26(13):4337-4345. PubMed ID: 31605348 [TBL] [Abstract][Full Text] [Related]
6. Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer. Yagata H; Yamauchi H; Tsugawa K; Hayashi N; Yoshida A; Kajiura Y; In R; Matsuda N; Nakamura S Clin Breast Cancer; 2013 Dec; 13(6):471-7. PubMed ID: 24267732 [TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy is a reliable method for lymph node evaluation in neoadjuvant chemotherapy-treated patients with breast cancer. Koslow SB; Eisenberg RE; Qiu Q; Chen Z; Swistel A; Shin SJ Am Surg; 2014 Feb; 80(2):171-7. PubMed ID: 24480218 [TBL] [Abstract][Full Text] [Related]
8. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer. Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899 [TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with operable breast cancer and positive axillary nodes at initial diagnosis. Rebollo-Aguirre AC; Gallego-Peinado M; Sánchez-Sánchez R; Pastor-Pons E; García-García J; Chamorro-Santos CE; Menjón-Beltrán S Rev Esp Med Nucl Imagen Mol; 2013; 32(4):240-5. PubMed ID: 23684711 [TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507 [TBL] [Abstract][Full Text] [Related]
11. Prediction of axillary response by monitoring with ultrasound and MRI during and after neoadjuvant chemotherapy in breast cancer patients. Eun NL; Son EJ; Gweon HM; Kim JA; Youk JH Eur Radiol; 2020 Mar; 30(3):1460-1469. PubMed ID: 31802216 [TBL] [Abstract][Full Text] [Related]
12. [Role of ultrasound-guided needle biopsy of ultrasonographic abnormal axillary lymph nodes in patients with breast cancer]. Ou YT; Li JF; Fan ZQ; Fan T; Wang TF; Xie YT; Lin BY Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):82-4. PubMed ID: 18353208 [TBL] [Abstract][Full Text] [Related]
13. Axillary staging using ultrasound-guided fine needle aspiration biopsy in locally advanced breast cancer. Oruwari JU; Chung MA; Koelliker S; Steinhoff MM; Cady B Am J Surg; 2002 Oct; 184(4):307-9. PubMed ID: 12383889 [TBL] [Abstract][Full Text] [Related]
14. Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy - Results from the multi-center SENTINA trial. Schwentner L; Helms G; Nekljudova V; Ataseven B; Bauerfeind I; Ditsch N; Fehm T; Fleige B; Hauschild M; Heil J; Kümmel S; Lebeau A; Schmatloch S; Schrenk P; Staebler A; Loibl S; Untch M; Von Minckwitz G; Liedtke C; Kühn T Breast; 2017 Feb; 31():202-207. PubMed ID: 27889596 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy. Khan A; Sabel MS; Nees A; Diehl KM; Cimmino VM; Kleer CG; Schott AF; Hayes DF; Chang AE; Newman LA Ann Surg Oncol; 2005 Sep; 12(9):697-704. PubMed ID: 16079956 [TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. Reitsamer R; Peintinger F; Rettenbacher L; Prokop E J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778 [TBL] [Abstract][Full Text] [Related]
17. Refining the Performance of Sentinel Lymph Node Biopsy Post-neoadjuvant Chemotherapy in Patients with Pathologically Proven Pre-treatment Node-positive Breast Cancer: An Update for Clinical Practice. El Hage Chehade H; Headon H; Kasem A; Mokbel K Anticancer Res; 2016 Apr; 36(4):1461-71. PubMed ID: 27069121 [TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis. Park S; Park JM; Cho JH; Park HS; Kim SI; Park BW Ann Surg Oncol; 2013 Sep; 20(9):2858-65. PubMed ID: 23645483 [TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy. Pecha V; Kolarik D; Kozevnikova R; Hovorkova K; Hrabetova P; Halaska M; Sottner O; Trnkova M; Petruzelka L; Kolarova H Cancer; 2011 Oct; 117(20):4606-16. PubMed ID: 21437896 [TBL] [Abstract][Full Text] [Related]
20. Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer. Hieken TJ; Boughey JC; Jones KN; Shah SS; Glazebrook KN Ann Surg Oncol; 2013 Oct; 20(10):3199-204. PubMed ID: 23846781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]